Insider trade

Legence (LGN): Director bought ~$250K

Terrence Keenen, Director at Legence, bought ~$250K of Legence shares.

~$250K
Approx. value · 8,928 sh @ $28.00
8,928
Holds after · shares reported
Traded
Sep 15, 2025
Filed
Sep 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 15, 2025 · this disclosureInsiderDirector purchased ~$250K of LGN shares in the open market

What came next

  1. Sep 15, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesChanged a top executive or board member, and signed an important agreement (and 4 more items)“On September 11, 2025, following the effective time of the Registration Statement, Terrence Keenen, Christie Kelly, Bilal Khan, Robert Mitchell Nimocks and Jeffrey Sprau were appointed to the Board of Directors of the Company (the “Board”).”
  2. Oct 30, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  3. Nov 13, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  4. Nov 14, 2025Company filing · Form 8-K · ResultsReported its results
  5. Nov 21, 2025Company filing · Form 8-K · Change of control, Other newsControl of the company changed hands, and reported other company news“On November 21, 2025, Legence Parent LLC and Legence Parent II LLC, affiliates of the investment funds associated with or designated by Blackstone Inc. that are the current majority owners of Legence Corp. (the “Company”), informed the Company as follows: “A wholly-owned subsidiary of Legence Parent LLC (such subsidiary, the “Facility 1 Borrower”) has entered into (i) a Margin Loan Agreement dated as of November 21,…”
  6. Nov 24, 2025CongressDisclosed purchase of LGN — reported range $1,001 - $15,000
  7. Dec 3, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 3, 2025, the Board of Directors (the “Board”) of Legence Corp., a Delaware corporation (the “Company”), increased the size of the Board from five to six directors and appointed Mr. David J. Coghlan to the Board as a Class I director to fill the vacancy created by such increase, effective as of December 3, 2025.”
  8. Jan 2, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 3 more items)“The information set forth in the “Introductory Note” and Item 1.01 of this Current Report is incorporated by reference in response to this”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Legence

For Legence, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LGN page.

How this filing works

Explore the data

Common questions

Which Legence (LGN) insider traded, and how much?

Terrence Keenen, Director at Legence, bought ~$250K of Legence shares. 8,928 shares at $28.00, open market.

When did it happen, and when was it made public?

Traded: Sep 15, 2025. Filed: Sep 16, 2025. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Legence recently?

For Legence, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the LGN page.

Does this mean LGN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Legence

Everything OQRO holds on this company is on its LGN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data